Search

everythinglearnresearchcommunity

for

Search:↓

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Patients need better information about the risks of long-term steroid use.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Low dose methotrexate does not increase hair fall and may reduce it.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Adalimumab can cause complete hair loss in rare cases.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.